Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Graefe's Archive for Clinical and Experimental Ophthalmology
Literature
1.
An SH, Kwon YH (2015) Effect of a topical nonsteroidal anti-inflammatory agent (0.1 % pranoprofen) on acute central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol
2.
3.
Piskunowicz M, Jaracz M, Lesiewska H, Malukiewicz G, Brozek-Pestka M, Borkowska A (2014) Temperament profile in patients with central serous chorioretinopathy: a case–control study. Eur J Ophthalmol 24(3):392–395CrossRefPubMed
4.
Drici MD, Raybaud F, De Lunardo C, Iacono P, Gustovic P (1995) Influence of the behaviour pattern on the nocebo response of healthy volunteers. Br J Clin Pharmacol 39(2):204–206CrossRefPubMedPubMedCentral
Metadata
Title
Comment on: “Effect of a topical nonsteroidal anti-inflammatory agent (0.1 % pranoprofen) on acute central serous chorioretinopathy”
Authors
Abdullah Kaya
Yakup Aksoy
Mehmet Koray Sevinç
Oktay Diner
Publication date
01-07-2016
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 7/2016
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-016-3277-2

Other articles of this Issue 7/2016

Graefe's Archive for Clinical and Experimental Ophthalmology 7/2016 Go to the issue

Trauma

Pediatric open-globe injuries: clinical characteristics and factors associated with poor visual and anatomical success

Book Review

Orbital Surgery (Esaso Course Series) Editors: R. Medel, L. M. Vásquez, F. Bandello, B. Corcóstegui (2014) ISBN: 978-3318026054 Publisher: Karger

Letter to the Editor

Re: Cho et al. “Long-term visual outcome and prognostic factors of intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation”

Retinal Disorders

An evaluation of two heavier-than-water internal limiting membrane-specific dyes during macular hole surgery

Review Article

Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment

Review Article

Ocriplasmin use for vitreomacular traction and macular hole: A meta-analysis and comprehensive review on predictive factors for vitreous release and potential complications